Sarepta Therapeutics Inc (SRPT)
116.76
-1.07
(-0.91%)
USD |
NASDAQ |
Apr 18, 13:59
Sarepta Therapeutics Gross Profit (Quarterly): 352.60M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 352.60M |
September 30, 2023 | 294.79M |
June 30, 2023 | 227.11M |
March 31, 2023 | 218.48M |
December 31, 2022 | 227.63M |
September 30, 2022 | 190.32M |
June 30, 2022 | 195.69M |
March 31, 2022 | 179.39M |
December 31, 2021 | 169.72M |
September 30, 2021 | 165.96M |
June 30, 2021 | 144.57M |
March 31, 2021 | 124.58M |
December 31, 2020 | 122.73M |
September 30, 2020 | 128.91M |
June 30, 2020 | 124.02M |
March 31, 2020 | 101.05M |
December 31, 2019 | 84.55M |
September 30, 2019 | 86.00M |
June 30, 2019 | 78.75M |
March 31, 2019 | 74.95M |
December 31, 2018 | 71.28M |
September 30, 2018 | 69.74M |
June 30, 2018 | 66.79M |
March 31, 2018 | 59.02M |
December 31, 2017 | 53.73M |
Date | Value |
---|---|
September 30, 2017 | 42.88M |
June 30, 2017 | 34.50M |
March 31, 2017 | 16.12M |
December 31, 2016 | 5.32M |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | 7.524M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
78.75M
Minimum
Jun 2019
352.60M
Maximum
Dec 2023
169.31M
Average
165.96M
Median
Sep 2021
Gross Profit (Quarterly) Benchmarks
CytomX Therapeutics Inc | -- |
PTC Therapeutics Inc | 277.94M |
Vertex Pharmaceuticals Inc | 2.150B |
Puma Biotechnology Inc | 47.86M |
Regenxbio Inc | 10.98M |